{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:25:05Z","timestamp":1790785505862,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intern Emerg Med"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s11739-026-04298-x","type":"journal-article","created":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T18:45:00Z","timestamp":1771613100000},"page":"1247-1258","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical features, diagnosis, and management of retroperitoneal fibrosis in a university referral hospital and literature review"],"prefix":"10.1007","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4754-0277","authenticated-orcid":false,"given":"Javier","family":"Loricera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Secada-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adri\u00e1n","family":"Mart\u00edn-Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Blanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Gonz\u00e1lez-Vela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,20]]},"reference":[{"key":"4298_CR1","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S0140-6736(06)68035-5","volume":"2","author":"A Vaglio","year":"2006","unstructured":"Vaglio A, Salvarani C (2006) Retroperitoneal fibrosis. Lancet 2:241\u2013251","journal-title":"Lancet"},{"key":"4298_CR2","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1681\/ASN.2015101110","volume":"27","author":"A Vaglio","year":"2016","unstructured":"Vaglio A, Maritati F (2016) Idiopathic retroperitoneal fibrosis. J Am Soc Nephrol 27:1880\u20131889","journal-title":"J Am Soc Nephrol"},{"key":"4298_CR3","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.juro.2010.09.105","volume":"185","author":"AS Brandt","year":"2011","unstructured":"Brandt AS, Kamper L, Kukuk S, Haage P, Roth S (2011) Associated findings and complications of retroperitoneal fibrosis in 204 patients: results of a urological registry. J Urol 185:526\u2013531","journal-title":"J Urol"},{"key":"4298_CR4","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1016\/S0022-5347(17)69482-5","volume":"59","author":"JK Ormond","year":"1948","unstructured":"Ormond JK (1948) Bilateral ureteral obstruction due to envelopment and compression by an inflammatory retroperitoneal process. J Urol 59:1072\u20131079","journal-title":"J Urol"},{"key":"4298_CR5","doi-asserted-by":"publisher","first-page":"297","DOI":"10.4065\/mcp.2010.0663","volume":"86","author":"TA Kermani","year":"2011","unstructured":"Kermani TA, Crowson CS, Achenbach SJ, Luthra HS (2011) Idiopathic retroperitoneal fibrosis: a retrospective review of clinical presentation, treatment, and outcomes. Mayo Clin Proc 86:297\u2013303","journal-title":"Mayo Clin Proc"},{"key":"4298_CR6","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1097\/MD.0b013e3181afc420","volume":"88","author":"EF van Bommel","year":"2009","unstructured":"van Bommel EF, Jansen I, Hendriksz TR, Aarnoudse AL (2009) Idiopathic retroperitoneal fibrosis: prospective evaluation of incidence and clinicoradiologic presentation. Medicine (Baltimore) 88:193\u2013201","journal-title":"Medicine (Baltimore)"},{"key":"4298_CR7","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1002\/art.21698","volume":"5","author":"D Martorana","year":"2006","unstructured":"Martorana D, Vaglio A, Greco P, Zanetti A, Moroni G, Salvarani C et al (2006) Chromic periaortitis and HLA-DRB1*03: another clue to an autoimmune origin. Arthritis Rheum 5:126\u2013130","journal-title":"Arthritis Rheum"},{"key":"4298_CR8","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.autrev.2014.08.006","volume":"14","author":"G Ceresini","year":"2015","unstructured":"Ceresini G, Urban ML, Corradi D et al (2015) Association between idiopathic retroperitoneal fibrosis and autoimmune thyroiditis: a case-control study. Autoimmun Rev 14:16\u201322","journal-title":"Autoimmun Rev"},{"key":"4298_CR9","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1097\/MD.0b013e3181afc4d1","volume":"88","author":"A Vaglio","year":"2009","unstructured":"Vaglio A (2009) Retroperitoneal fibrosis: new insights into clinical presentation and diagnosis. Medicine (Baltimore) 88:208\u2013210","journal-title":"Medicine (Baltimore)"},{"key":"4298_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s41927-024-00445-z","volume":"9","author":"A Steimer","year":"2025","unstructured":"Steimer A, Becker MO (2025) Treatment approaches for idiopathic retroperitoneal fibrosis: a systemic review with meta-analysis. BMC Rheumatol 9:12","journal-title":"BMC Rheumatol"},{"key":"4298_CR11","doi-asserted-by":"publisher","first-page":"423","DOI":"10.2214\/AJR.07.3629","volume":"191","author":"CG Cronin","year":"2008","unstructured":"Cronin CG, Lohan DG, Blake MA, Roche C, McCarthy P, Murphy JM (2008) Retroperitoneal fibrosis: a review of clinical features and imaging findings. AJR Am J Roentgenol 191:423\u2013431","journal-title":"AJR Am J Roentgenol"},{"key":"4298_CR12","doi-asserted-by":"publisher","first-page":"370","DOI":"10.3109\/00365599.2012.747564","volume":"47","author":"I G\u00f3mez-Garc\u00eda","year":"2013","unstructured":"G\u00f3mez-Garc\u00eda I, S\u00e1nchez Castano A, Romero Molina M et al (2013) Retroperitoneal fibrosis: single-centre experience from 1992 to 2010, current status of knowledge and review of the international literature. Scand J Urol 47:370\u2013377","journal-title":"Scand J Urol"},{"key":"4298_CR13","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1007\/s00296-014-3002-6","volume":"34","author":"H Liu","year":"2014","unstructured":"Liu H, Zhang G, Niu Y, Jiang N, Xiao W (2014) Retroperitoneal fibrosis: a clinical and outcome analysis of 58 cases and review of literature. Rheumatol Int 34:1665\u20131670","journal-title":"Rheumatol Int"},{"key":"4298_CR14","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1080\/0886022X.2022.2064303","volume":"44","author":"I Lon","year":"2022","unstructured":"Lon I, Lewandowski J, Wieliczko M, Malyszko J (2022) Retroperitoneal fibrosis, a rare entity with urorenal and vascular subtypes -preliminary data. Ren Fail 44:688\u2013692","journal-title":"Ren Fail"},{"key":"4298_CR15","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-025-04847-6","author":"S Czerniak","year":"2025","unstructured":"Czerniak S, Mathur M (2025) Multimodality imaging review of retroperitoneal fibrosis. Abdom Radiol (NY). https:\/\/doi.org\/10.1007\/s00261-025-04847-6","journal-title":"Abdom Radiol (NY)"},{"key":"4298_CR16","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.mehy.2018.11.005","volume":"122","author":"A Soriano Rios","year":"2019","unstructured":"Soriano Rios A, Paredes H, Hernandez Calleros J, Uscanga-Dominguez L, Pelaez-Luna M (2019) Retroperitoneal fibrosis. Steroid treatment response seems to depend on its association to IgG4 related disease. Med Hypotheses 122:120\u2013123","journal-title":"Med Hypotheses"},{"key":"4298_CR17","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1080\/03009742.2018.1497700","volume":"48","author":"J Zhao","year":"2019","unstructured":"Zhao J, Li J, Zhang Z (2019) Long-term outcomes and predictors of a large cohort of idiopathic retroperitoneal fibrosis patients: a retrospective study. Scand J Rheumatol 48:239\u2013245","journal-title":"Scand J Rheumatol"},{"key":"4298_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0040296","volume":"4","author":"E Von Elm","year":"2007","unstructured":"Von Elm E, Altman DG, Egger M et al (2007) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. PLoS Med 4:e296","journal-title":"PLoS Med"},{"key":"4298_CR19","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","volume":"39","author":"B Williams","year":"2018","unstructured":"Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M et al (2018) ESC\/ESH guidelines for the management of arterial hypertension. Eur Heart J 39:3021\u20133104","journal-title":"Eur Heart J"},{"key":"4298_CR20","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.19123","volume":"4","author":"OY Addo","year":"2021","unstructured":"Addo OY, Yu EX, Williams AM, Young MF, Sharma AJ, Mei Z, Kassebaum NJ, Jefferds MED, Suchdev PS (2021) Evaluation of hemoglobin cutoff levels to define anemia among healthy individuals. JAMA Netw Open 4:e2119123","journal-title":"JAMA Netw Open"},{"key":"4298_CR21","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13643-021-01626-4","volume":"10","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al (2021) The PRISMA 2020 estatement: an updated guideline for reporting systematic reviews. Syst Rev 10:89","journal-title":"Syst Rev"},{"key":"4298_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-021-02627-3","volume":"23","author":"SJ Lee","year":"2021","unstructured":"Lee SJ, Eun JS, Kim MJ et al (2021) Association of retroperitoneal fibrosis with malignancy and its outcomes. Arthritis Res Ther 23:249","journal-title":"Arthritis Res Ther"},{"key":"4298_CR23","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/s10067-024-07276-w","volume":"44","author":"J-Q Hu","year":"2025","unstructured":"Hu J-Q, Jin Z-Y, Yu Y-Y, Min D-M, Cai Q, Gao J (2025) Clinical characteristics of IgG4-related retroperitoneal fibrosis in a cohort of 117 patients with idiopathic retroperitoneal fibrosis: a retrospective study. Clin Rheumatol 44:757\u2013766","journal-title":"Clin Rheumatol"},{"key":"4298_CR24","first-page":"527","volume":"77","author":"M Ando","year":"2023","unstructured":"Ando M, Hanayama Y, Nishimura Y, Hagiya H, Otsuka F (2023) Clinical characteristics of retroperitoneal fibrosis patients at a tertiary hospital in Japan. Acta Med Okayama 77:527\u2013536","journal-title":"Acta Med Okayama"},{"key":"4298_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1435870","volume":"11","author":"H Liu","year":"2024","unstructured":"Liu H, Gao H, Zhao J-X, Wong U-K, Liu S-B, Liu J et al (2024) Outcomes of retroperitoneal fibrosis-related hydronephrosis and its risk factors for poor prognosis: a multi-center retrospective cohort study in Chinese patients. Front Med (Lausanne) 11:1435870","journal-title":"Front Med (Lausanne)"},{"key":"4298_CR26","doi-asserted-by":"publisher","first-page":"3676","DOI":"10.1093\/rheumatology\/keae676","volume":"64","author":"Y Chao","year":"2025","unstructured":"Chao Y, Li R, Shao Y, Fei Y, Zhou J, Zhao L (2025) Factors associated with early clinical remission in patients with idiopathic retroperitoneal fibrosis. Rheumatology (Oxford) 64:3676\u20133684","journal-title":"Rheumatology (Oxford)"},{"key":"4298_CR27","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1053\/j.ajkd.2019.04.020","volume":"74","author":"F Raffiotta","year":"2019","unstructured":"Raffiotta F, da Silva Escoli R, Quaglini S, Rognoni C, Sacchi L, Binda V et al (2019) Idiopathic retroperitoneal fibrosis: long-term risk and predictors of relapse. Am J Kidney Dis 74:742\u2013750","journal-title":"Am J Kidney Dis"},{"key":"4298_CR28","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1080\/03009742.2017.1363280","volume":"47","author":"S Liao","year":"2018","unstructured":"Liao S, Wang Y, Li K, Zhu J, Zhang J, Huang F (2018) Idiopathic retroperitoneal fibrosis: a cross-sectional study of 142 Chinese patients. Scand J Rheumatol 47:198\u2013205","journal-title":"Scand J Rheumatol"},{"key":"4298_CR29","first-page":"1642","volume":"40","author":"E Zampeli","year":"2022","unstructured":"Zampeli E, Venetsanopoulou AI, Christaki S, Argyropoulou OD, Boki KA, Manoussakis MN et al (2022) Idiopathic retroperitoneal fibrosis: clinical features, treatment modalities, relapse rate in Greek patients and a review of the literature. Clin Exp Rheumatol 40:1642\u20131649","journal-title":"Clin Exp Rheumatol"},{"key":"4298_CR30","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1111\/iju.14218","volume":"27","author":"T Tanaka","year":"2020","unstructured":"Tanaka T, Masumori N (2020) Current approach to diagnosis and management of retroperitoneal fibrosis. Int J Urol 27:387\u2013394","journal-title":"Int J Urol"},{"key":"4298_CR31","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-020-00966-9","volume":"23","author":"P Fenaroli","year":"2021","unstructured":"Fenaroli P, Maritati F, Vaglio A (2021) Into clinical practice: diagnosis and therapy of retroperitoneal fibrosis. Curr Rheumatol Rep 23:18","journal-title":"Curr Rheumatol Rep"},{"key":"4298_CR32","first-page":"19","volume":"3","author":"I Sinescu","year":"2010","unstructured":"Sinescu I, Surcel C, Mirvald C et al (2010) Prognostic factors in retroperitoneal fibrosis. J Med Life 3:19\u201325","journal-title":"J Med Life"},{"key":"4298_CR33","first-page":"250","volume":"81","author":"L Koep","year":"1977","unstructured":"Koep L, Zuidema GD (1977) The clinical significance of retroperitoneal fibrosis. Surgery 81:250\u2013257","journal-title":"Surgery"},{"key":"4298_CR34","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1007\/s11739-025-03908-4","volume":"20","author":"C Secada-G\u00f3mez","year":"2025","unstructured":"Secada-G\u00f3mez C, Loricera J, Mart\u00edn-Guti\u00e9rrez A et al (2025) Clinical characterization of aortitis and periaortitis: study of 134 patients from a single university hospital. Intern Emerg Med 20:1045\u20131057","journal-title":"Intern Emerg Med"},{"key":"4298_CR35","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2023-003026","volume":"9","author":"M Kanda","year":"2023","unstructured":"Kanda M, Kamekura R, Sugawara M et al (2023) Igg4-related disease administered dupilumab: case series and review of the literature. RMD Open 9:e003026","journal-title":"RMD Open"},{"key":"4298_CR36","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1177\/03915603241270453","volume":"92","author":"A Mehedra","year":"2025","unstructured":"Mehedra A, Maachi Y, Babty M, Slaoui A, Karmouni T, Elkhader K et al (2025) Exploring retroperitoneal fibrosis: insights, challenges, and treatment approaches. Urologia 92:14\u201320","journal-title":"Urologia"},{"key":"4298_CR37","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.ejim.2012.11.010","volume":"24","author":"EF van Bommel","year":"2013","unstructured":"van Bommel EF, Pelkmans LG, van Damme H, Hendriksz TR (2013) Long-term safety and efficacy of tamoxifen-based treatment strategy for idiopathic retroperitoneal fibrosis. Eur J Intern Med 24:444\u2013450","journal-title":"Eur J Intern Med"},{"key":"4298_CR38","doi-asserted-by":"publisher","first-page":"31","DOI":"10.7326\/0003-4819-154-1-201101040-00005","volume":"154","author":"PJ Scheel Jr","year":"2011","unstructured":"Scheel PJ Jr, Feeley N, Sozio SM (2011) Combined prednisone and mycophenolate mofetil treatment for retroperitoneal fibrosis: a case series. Ann Intern Med 154:31\u201336","journal-title":"Ann Intern Med"},{"key":"4298_CR39","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/S0022-5347(05)64677-0","volume":"168","author":"AK Kardar","year":"2002","unstructured":"Kardar AK, Kattan S, Lindstedt E, Hanash K (2002) Steroid therapy for idiopathic retroperitoneal fibrosis: dose and duration. J Urol 168:550\u2013555","journal-title":"J Urol"},{"key":"4298_CR40","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1001\/archinte.1985.00360040191043","volume":"145","author":"E Cogan","year":"1985","unstructured":"Cogan E, Fastrez R (1985) Azathioprine. An alternative treatment for recurrent idiopathic retroperitoneal fibrosis. Arch Intern Med 145:753\u2013755","journal-title":"Arch Intern Med"},{"key":"4298_CR41","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1136\/annrheumdis-2011-200148","volume":"71","author":"M Binder","year":"2012","unstructured":"Binder M, Uhi M, Wiech T et al (2012) Cyclophosphamide is a highly effective and safe induction therapy in chronic periaortitis: a long-term follow-up of 35 patients with chronic periaortitis. Ann Rheum Dis 71:311\u2013312","journal-title":"Ann Rheum Dis"},{"key":"4298_CR42","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1136\/annrheumdis-2013-203267","volume":"72","author":"F Alberici","year":"2013","unstructured":"Alberici F, Palmisano A, Urban ML et al (2013) Methotrexate plus prednisone in patients with relapsing idiopathic retroperitoneal fibrosis. Ann Rheum Dis 72:1584\u20131586","journal-title":"Ann Rheum Dis"},{"key":"4298_CR43","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1136\/ard.60.4.427","volume":"60","author":"A Marzano","year":"2001","unstructured":"Marzano A, Trapani A, Leone N, Actis GC, Rizzetto M (2001) Treatment of idiopathic retroperitoneal fibrosis using cyclosporin. Ann Rheum Dis 60:427\u2013428","journal-title":"Ann Rheum Dis"},{"key":"4298_CR44","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1159\/000526114","volume":"107","author":"D Giannese","year":"2023","unstructured":"Giannese D, Moriconi D, Cupisti A et al (2023) Idiopathic retroperitoneal fibrosis: what is the optimal clinical approach for long-term preservation of renal function? Urol Int 107:134\u2013147","journal-title":"Urol Int"},{"key":"4298_CR45","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1089\/end.2019.0309","volume":"33","author":"S Weltings","year":"2019","unstructured":"Weltings S, Schout BMA, Roshani H et al (2019) Lessons from literature: nephrostomy versus double J ureteral characterization in patients with obstructive urolithiasis\u2014which method is superior? J Endourol 33:777\u2013786","journal-title":"J Endourol"}],"container-title":["Internal and Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-026-04298-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11739-026-04298-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-026-04298-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T12:02:00Z","timestamp":1781265720000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11739-026-04298-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,20]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["4298"],"URL":"https:\/\/doi.org\/10.1007\/s11739-026-04298-x","relation":{},"ISSN":["1828-0447","1970-9366"],"issn-type":[{"value":"1828-0447","type":"print"},{"value":"1970-9366","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,20]]},"assertion":[{"value":"27 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Disclosures that could be interpreted as potential conflicts of interest related to this study: J. Loricera had consultation fees\/participation in company-sponsored speaker\u00b4s bureau from Roche, AbbVie, Gal\u00e1pagos, Alpha Sigma, Novartis, UCB Pharma, MSD, Celgene, Astra Zeneca, and Gr\u00fcnenthal and received support for attending meetings and\/or travel from Janssen, AbbVie, Roche, Novartis, MSD, UCB Pharma, Celgene, Lilly, Pfizer, and Gal\u00e1pagos. R. Blanco received grants\/research support from AbbVie, MSD, and Roche, and had consultation fees\/participation in a company-sponsored speaker\u2019s bureau from AbbVie, Pfizer, Roche, GSK, Lilly, UCB, Bristol-Myers, Novartis, Janssen, UCB and MSD, and received support for attending meetings and\/or travel from AbbVie, Pfizer, Roche, GSK, Lilly, UCB, Bristol-Myers, Novartis, Janssen, UCB, and MSD.\n                      The following authors did not declare financial disclosure:\n                      C. Secada-G\u00f3mez and A. Mart\u00edn-Guti\u00e9rrez and MC Gonzalez-Vela.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the Cantabria Clinical Research Ethics Committee (internal code 2023.440, signed on 02 February 2024) and was conducted in accordance with the Declaration of Helsinki and the International Conference on Harmonization guidelines. All data extracted from medical records were anonymized prior to analysis.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"According to national legislation and the Ethics Committee, informed consent was not required for this retrospective study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"No.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Use of AI and AI-assisted technologies in the writing process"}}]}}